Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Peleg

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Steroids|April 7, 2000
Synthesis and biological activities of the two C(23) epimers of 1alpha,23,25-trihydroxy-24-oxo-19-nor-vitamin D(3): novel analogs of 1alpha,23(S),25-trihydroxy-24-oxo-vitamin D(3), a natural metabolite of 1alpha,25-dihydroxyvitamin D(3)N E Lee, P G Williard, A J Brown, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 1, 1996
1alpha,25-dihydroxy-24-oxo-16-ene vitamin D3, a metabolite of a synthetic vitamin D3 analog, 1alpha,25-dihydroxy-16-ene vitamin D3, is equipotent to its parent in modulating growth and differentiation of human leukemic cellsM L Siu-Caldera, J W Clark, A Santos-Moore, et al.
Molecular Cytogenetics|March 22, 2022
New insights regarding origin of monosomy occurrence in early developing embryos as demonstrated in preimplantation genetic testingN Samara, S Peleg, T Frumkin, et al.
Bioorganic & Medicinal Chemistry|September 13, 2001
A non-calcemic sulfone version of the vitamin D(3) analogue seocalcitol (EB 1089): chemical synthesis, biological evaluation and potency enhancement of the anticancer drug adriamycinG H Posner, K R Crawford, S Peleg, et al.
Journal of Cellular Biochemistry|August 14, 2001
Tissue specific metabolism of 1alpha,25-dihydroxy-20-epi-vitamin D3 into new metabolites with significant biological activity: studies in rat osteosarcoma cells (UMR 106 and ROS 17/2.8)M L Siu-Caldera, D S Rao, N Astecker, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 5, 2000
Enhanced biological activity of 1alpha,25-dihydroxy-20-epi-vitamin D3, the C-20 epimer of 1alpha,25-dihydroxyvitamin D3, is in part due to its metabolism into stable intermediary metabolites with significant biological activityM L Siu-Caldera, H Sekimoto, S Peleg, et al.
Journal of Medicinal Chemistry|July 14, 2000
Characterization of a novel analogue of 1alpha,25(OH)(2)-vitamin D(3) with two side chains: interaction with its nuclear receptor and cellular actionsA W Norman, P S Manchand, M R Uskokovic, et al.
Cancer Research|July 17, 2001
Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathwayJ Yang, K Fizazi, S Peleg, et al.
Journal of Medicinal Chemistry|September 23, 2000
Conceptually new 20-epi-22-oxa sulfone analogues of the hormone 1alpha,25-dihydroxyvitamin D(3): synthesis and biological evaluationG H Posner, K Crawford, M L Siu-Caldera, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Steroids|April 7, 2000
Synthesis and biological activities of the two C(23) epimers of 1alpha,23,25-trihydroxy-24-oxo-19-nor-vitamin D(3): novel analogs of 1alpha,23(S),25-trihydroxy-24-oxo-vitamin D(3), a natural metabolite of 1alpha,25-dihydroxyvitamin D(3)N E Lee, P G Williard, A J Brown, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 1, 1996
1alpha,25-dihydroxy-24-oxo-16-ene vitamin D3, a metabolite of a synthetic vitamin D3 analog, 1alpha,25-dihydroxy-16-ene vitamin D3, is equipotent to its parent in modulating growth and differentiation of human leukemic cellsM L Siu-Caldera, J W Clark, A Santos-Moore, et al.
Molecular Cytogenetics|March 22, 2022
New insights regarding origin of monosomy occurrence in early developing embryos as demonstrated in preimplantation genetic testingN Samara, S Peleg, T Frumkin, et al.
Bioorganic & Medicinal Chemistry|September 13, 2001
A non-calcemic sulfone version of the vitamin D(3) analogue seocalcitol (EB 1089): chemical synthesis, biological evaluation and potency enhancement of the anticancer drug adriamycinG H Posner, K R Crawford, S Peleg, et al.
Journal of Cellular Biochemistry|August 14, 2001
Tissue specific metabolism of 1alpha,25-dihydroxy-20-epi-vitamin D3 into new metabolites with significant biological activity: studies in rat osteosarcoma cells (UMR 106 and ROS 17/2.8)M L Siu-Caldera, D S Rao, N Astecker, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 5, 2000
Enhanced biological activity of 1alpha,25-dihydroxy-20-epi-vitamin D3, the C-20 epimer of 1alpha,25-dihydroxyvitamin D3, is in part due to its metabolism into stable intermediary metabolites with significant biological activityM L Siu-Caldera, H Sekimoto, S Peleg, et al.
Journal of Medicinal Chemistry|July 14, 2000
Characterization of a novel analogue of 1alpha,25(OH)(2)-vitamin D(3) with two side chains: interaction with its nuclear receptor and cellular actionsA W Norman, P S Manchand, M R Uskokovic, et al.
Cancer Research|July 17, 2001
Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathwayJ Yang, K Fizazi, S Peleg, et al.
Journal of Medicinal Chemistry|September 23, 2000
Conceptually new 20-epi-22-oxa sulfone analogues of the hormone 1alpha,25-dihydroxyvitamin D(3): synthesis and biological evaluationG H Posner, K Crawford, M L Siu-Caldera, et al.
Pageof 6